Subscribe


Pharmacy Daily

PD breaking news – Sigma cracks $100 million in “underlying profit”

Sales to Sigma-branded pharmacies up 8.2% following heavy investment in national retail brands. 

Sigma Pharmaceuticals has just released its results for the year to 31 January 2017, with ceo Mark Hooper saying the underlying profit figure of $100.2 million, an increase of 12.4%, was the result of a “consistent execution of our strategy”.

However the reported EBIT figure rose just 1.1% to $80.9 million, once the previously announced $20 million in extraordinary items was taken into account. That included an $11.4 million insurance premium recovery claim and $8.3 million relating to a doubtful debt owed by a “single pharmacy group”. The group was not named in the results announcement.

Hooper said these were both “one-off impacts reflecting historical issues” with Sigma’s strategy going forward focusing on diversifying the business by seeking opportunities to grow non-PBS earnings.

Revenue rose 26.2% to $4.4 billion, including the impact of the new hepatitis C medicines. Hooper said non-PBS medicines now account for 55% of volume distributed, and 36% of total revenue excluding hepatitis C.

Sigma has invested heavily in its pharmacy network, with like-for-like sales to Sigma branded pharmacies up 8.2% for the 12 month period. “We have leveraged our scale to invest significantly in our national retail brands and patient focussed programs over the past few years, and we now have the most compelling offer in the market,” Hooper said.

He also confirmed that shareholders will be asked to approve a change of company name to Sigma Healthcare Limited on 3 May 2017, with the ASX ticker to also change from SIP to SIG.

More information in tomorrow’s issue of Pharmacy Daily.


The above Breaking News Alert was sent to Pharmacy Daily subscribers on 23 Mar 17

Make a comment...



Established in 2007, Pharmacy Daily is Australia's leading pharmacy industry publication, and is sent as a free subscription to people across the industry as a PDF newsletter every weekday.

Register for Pharmacy Daily trial subscription

To sign up for a free subscription, click on the button at right.

Click here to see a sample issue of Pharmacy Daily.

Click here for more information on subscriptions.

Alternatively, you can search our site via the search box on the right hand side of the page, or find other content below.

Recent Pharmacy Daily articles

19 Feb

Weekly Comment 19 Feb 18: Promoting your personal brand - THIS week's contributor is Heidi Dariz, General ...


19 Feb

Dispensary Corner 19 Feb 18 - PEOPLE can remain very loyal to their ...


19 Feb

Arthrem safety alert - NEW Zealand Medicines and Medical Devices Safety ...


19 Feb

Roche to buy Flatiron - ROCHE has announced it has signed a ...


19 Feb

Gannon slams vaping - AMA president Michael Gannon has highlighted the ...


19 Feb

FDA guidance x seven - THE US Food and Drug Administration (FDA) ...


19 Feb

Potent new flu vaccine - A NEW high dose influenza vaccine will ...


19 Feb

Schulze WA POTY - FORMER PDL chairman and current chairman of ...


19 Feb

WA Guild elections - NOMINATIONS are open for the election of ...


19 Feb

‘Pharmacy first’ says NHS - PARENTS of young children with minor illnesses ...


19 Feb

Med cannabis challenges - WITH society's growing demand for access to ...


16 Feb

Events Calendar 16 Feb 18 - 16-18 Mar: Annual Therapeutic Update 2018; Fairmont ...


16 Feb

Dispensary Corner 16 Feb 18 - THE man famed for being the fifth ...


16 Feb

Choose pain Rx wisely - NPS MedicineWise has released through its Choosing ...


16 Feb

TRUST FENMOL recall - PHARMACEUTICAL manufacturer Pharmacor in conjunction with the ...


16 Feb

PDL offers free PI - PHARMACEUTICAL Defence Limited is highlighting its offer ...


16 Feb

Bill amended - THE Therapeutic Goods Amendment (2017) Bill was ...


16 Feb

Photopheresis alert - HEALTH professionals and consumers are being advised ...


16 Feb

Opdivo for bladders - THE Therapeutic Goods Administration has announced approval ...


16 Feb

Holista inks $6m deal - ASX-LISTED Perth-based biotech Holista CollTech, focused on ...



Show Pharmacy Daily items by month: